Biotech

Gene Therapy of treatment and adjustment of DNA
Manufacturing

Acuitas takes majority stake in Montreal-based RNA manufacturer

Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based RNA Technologies & Therapeutics.
Joseph Keenan Jan 8, 2026 9:12am
HIV AIDS PREP
Favicon Fierce Biotech

Study finds HIV can evolve to resist lenacapavir—at a cost

Jan 7, 2026 2:00pm
Ziihera

Jazz touts Ziihera as HER2 agent of choice in stomach cancer

Jan 6, 2026 3:25pm
An envelope with rejected mark Vector illustration
Favicon Fierce Biotech

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am
Monjuvi

Incyte to seek FDA approval for Monjuvi in front-line DLBCL

Jan 5, 2026 10:40am
Stop sign

Verastem nixes KRAS G12C plans in non-small cell lung cancer

Jan 2, 2026 10:10am